Dr.Supadej Rojphaisarn

Dr. Supadej Rojphaisarn is a leading expert in the field of stem cell research, currently serving as the Head of the Stem Cell Research Project at Stem Cell for Life, Greater Pharma. With a robust academic foundation, including a PhD in Stem Cell and Molecular Biology from Thammasat University, Dr. Rojphaisarn has dedicated over a decade to advancing the understanding and application of stem cell science. His extensive experience includes significant roles as a Research Assistant at prestigious institutions such as the Faculty of Medicine, Siriraj Hospital, and Thammasat University, where he focused on cell and molecular biology. Dr. Rojphaisarn's research contributions are noteworthy, particularly in the characterization of mesenchymal stem cells and their therapeutic potential. His work has been published in reputable journals, highlighting his commitment to exploring innovative treatments for various diseases. Notably, he presented groundbreaking findings on the anti-acute graft-versus-host disease effects of human postnatal organ- and bone marrow-derived mesenchymal stem cells at the 1st Academic Science and Technology Conference in 2013, underscoring his role as a thought leader in the field. With a clinical approach that emphasizes the regenerative capabilities of stem cells, Dr. Rojphaisarn is dedicated to translating research into practical therapies that enhance patient outcomes. His philosophy centers on the integration of scientific inquiry with compassionate care, ensuring that advancements in stem cell technology are accessible and beneficial to those in need. As he continues to lead innovative research initiatives, Dr. Rojphaisarn remains committed to pushing the boundaries of medical science, fostering a future where stem cell therapies play a pivotal role in healthcare.